On the morning of July 18, Wu Meng, deputy governor of Beijing Daxing District People's Government, Wang Qunhui, Party secretary and director of the District Science and Technology Committee, Gao Bingyang, Party secretary and director of the District Economic and Information Technology Bureau, Jiao Deep Sea, Party secretary and director of the District Foreign Affairs Service Center, Wang Yuexuan, investment Commissioner and other parties visited Shenzhen Cell Valley. Shenzhen Cell Valley chairman Shi Yuanyuan, deputy general manager Tang Xiaomeng, Chairman assistant Wei Zheng, research and development department head Zhao Lijun, general office director Luan Zhishi, Marketing Department director Gulina heat, Halimu and other warm reception.


The leadership of Daxing District of Beijing, accompanied by Chairman Shi Yuan, visited the administrative office area, production workshop and R&D laboratory of Shenzhen Cell Valley, and learned about the company's founder team, enterprise development history, CAR-T history, service platform construction, South China Cell factory project scale, laboratory and production workshop layout.

In the subsequent symposium, Shi Yuan reported to the leaders of Daxing District the relevant situation of the wholly-owned subsidiary Jingshen Cell Valley in Daxing District, and explained in detail the industry background of cell and gene therapy, market development trend, the advantages of the company's core technology - GMP industrial production of retroviral vector, and the concept of service platform construction. Shenzhen Cell Valley, as a link of exchange and cooperation between relevant enterprises, government review institutions and scientific research institutes, provides multi-channel, multi-level, multi-functional and all-round public services for product research and development and transformation of results, and provides a full-chain technology platform for the upper, middle and downstream of the cell therapy industry. Wu Meng, vice governor of Shenzhen Cell Valley, highly recognized the corporate philosophy of Shenzhen Cell Valley, and paid attention to the promotion of Jingshen Cell Valley, a wholly-owned subsidiary of Shenzhen Cell Valley, settling in Daxing District; Director Wang Qunhui expressed his willingness to provide relevant policy support to promote the standardized development of cell and gene therapy industry in Daxing District; Director Gao Bingyang said that he will continue to maintain communication with the Cell Valley team, provide comprehensive support such as policy interpretation, government services, and park entry coordination, timely solve the problems faced by enterprises, create a good new form of business in the biomedical industry, and promote the strategic development of the biomedical industry.

Shi Yuan said that the layout of Daxing District in Beijing is an extremely important part of the rapid development of Shenzhen Cell Valley. This exchange further promoted the process of Shenzhen Cell Valley R&D headquarters (namely Jingshen Cell Valley) landing. Cell Valley will make full use of the advanced technology and talent reserve of the overseas returnee founder team, aiming to solve the pain points and card points in the field of domestic cell gene therapy, help build and integrate the construction of cell drug industry chain, and contribute to promoting the transformation of biomedical scientific research results and driving the high-quality development of domestic cell and gene therapy industry. Finally, Shi Yuan expressed his heartfelt thanks to the leaders of Daxing District of Beijing for their presence and concern, and took a group photo with them.